AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

TNR Gold Corp.

CAD 0.24 +$0.08 (+50.00%)
TSXV · 15 Sep 2026 19:58 UTC
Previous Close
CAD 0.27
Day Range
CAD 0.24CAD 0.28
Year Range
CAD 0.09CAD 0.36
Market Cap
57.14M
AVG Volume
238.08K
Trailing/Forward PE
-26.37/-
PEG ratio
0.47
Dividend Yield
-
Next Earnings Date
2026-11-26
Primary Exchange
Toronto Stock Exchange VenturesCA
Net Income (CAD)
-1M-750K-500K-250K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Net Income (CAD) by quarter
PeriodNet Income (CAD)
26 Q2-309.04K
26 Q1-852.38K
25 Q4-294.42K
25 Q3-509.62K
25 Q2-249.98K
25 Q1-206.36K
24 Q4-353.64K
24 Q3-205.79K
24 Q2-234.28K
24 Q1-221.61K
Operating Income (CAD)
-1M-750K-500K-250K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
26 Q2-307.72K
26 Q1-852.14K
25 Q4-292.85K
25 Q3-509.32K
25 Q2-249.63K
25 Q1-205.76K
24 Q4-351.47K
24 Q3-205.07K
24 Q2-233.19K
24 Q1-230.83K
EBITDA (CAD)
-1M-750K-500K-250K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
26 Q2-307.24K
26 Q1-851.65K
25 Q4-291.48K
25 Q3-508.12K
25 Q2-248.69K
25 Q1-205.51K
24 Q4-350.17K
24 Q3-204K
24 Q2-232.28K
24 Q1-219.33K
Cash Flows (CAD)
-600K-400K-200K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
26 Q2-473.91K
26 Q1-150.97K
25 Q4-281.29K
25 Q3-221.98K
25 Q2-548
25 Q1-56.45K
24 Q4-94
24 Q3-249.49K
24 Q2-258.23K
24 Q1-217.41K
EPS (CAD)
-0-0-0-0024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V EPS (CAD) by quarter
PeriodEPS (CAD)
26 Q2-0
26 Q1-0
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
Expenses (CAD)
0200K400K600K800KSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Expenses (CAD) by quarter
PeriodExpenses (CAD)
26 Q2307.24K
26 Q1784.34K
25 Q4291.48K
25 Q3439.38K
25 Q2180.52K
25 Q1146.04K
24 Q4315.35K
24 Q3145.24K
24 Q2198.16K
24 Q1230.29K
Cash & Debt (CAD)
01M2M3M4MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
26 Q23.77M
26 Q126.46K
25 Q421.42K
25 Q3110.2K
25 Q2262.15K
25 Q115.83K
24 Q412.31K
24 Q3106.38K
24 Q246.87K
24 Q1312.71K
Debt ratios
00.511.5224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Debt ratios by quarter
PeriodDebt ratios
26 Q21.92
26 Q10.01
25 Q40.02
25 Q30.08
25 Q20.26
25 Q10.02
24 Q40.01
24 Q30.1
24 Q20.04
24 Q10.2
Return on Capital
-1000%-500%0%500%1000%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Return on Capital by quarter
PeriodReturn on Capital
26 Q2-8.23%
26 Q1562.22%
25 Q4-727.33%
25 Q3-292.4%
25 Q2-78.32%
25 Q191.37%
24 Q4444.89%
24 Q3-105.58%
24 Q2-255.46%
24 Q1-66.43%
Shares Outstanding
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2224.58M
26 Q1212.23M
25 Q4210.41M
25 Q3218.22M
25 Q2197.78M
25 Q1190.3M
24 Q4190.06M
24 Q3187.42M
24 Q2184.91M
24 Q1185.56M
Book Value Per Share (CAD)
-0.0100.010.010.010.0224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
26 Q20.02
26 Q1-0
25 Q40
25 Q30
25 Q20
25 Q1-0
24 Q4-0
24 Q30
24 Q20
24 Q10
Total Assets (CAD)
01M2M3M4M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNR.V Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
26 Q23.83M
26 Q172.42K
25 Q4112.82K
25 Q3207.42K
25 Q2361.95K
25 Q160.81K
24 Q474.51K
24 Q3201.14K
24 Q2104.67K
24 Q1365.03K
PE Ratio
0102030med 1.65Oct 17Jan 18May 18Aug 23Dec 23Mar 24Jun 24
TNR.V PE Ratio by quarter
PeriodPE Ratio
Jun 241.31
Jun 241.31
Jun 241.42
Jun 241.42
May 241.66
May 241.66
May 241.54
May 241.54
May 241.42
Apr 241.42
Apr 241.42
Apr 241.42
Apr 241.31
Mar 241.16
Mar 241.16
Mar 241.28
Mar 241.28
Mar 241.28
Feb 241.28
Feb 241.28
Feb 241.39
Feb 241.28
Jan 241.28
Jan 241.28
Jan 241.39
Jan 241.28
Dec 231.28
Dec 231.28
Dec 231.28
Dec 231.28
Dec 231.28
Nov 231.28
Nov 231.28
Nov 231.28
Nov 231.28
Oct 231.28
Oct 231.63
Oct 231.63
Oct 231.63
Sep 231.7
Sep 231.25
Sep 231.36
Sep 231.36
Sep 231.36
Aug 231.36
Aug 231.48
Aug 231.48
Aug 231.48
Jul 231.59
Jul 231.48
Jul 231.36
Jul 231.25
Jun 231.25
Jun 185.34
Jun 186.53
Jun 185.94
Jun 184.75
May 184.75
May 184.75
May 185.94
May 185.94
Apr 184.75
Apr 184.75
Apr 184.16
Apr 184.16
Mar 188.08
Mar 187.18
Mar 186.28
Mar 187.18
Mar 186.28
Feb 186.28
Feb 187.18
Feb 187.18
Feb 188.97
Jan 1811.67
Jan 1812.56
Jan 1812.56
Jan 1810.77
Dec 1711.67
Dec 1723.32
Dec 1725.11
Dec 1719.73
Dec 1723.32
Nov 1723.32
Nov 1721.53
Nov 1721.53
Nov 1723.32
Oct 1721.53
Oct 1717.94
Oct 1719.73
Oct 1716.14
Sep 1714.35
Sep 176.06
Sep 176.06
Sep 176.82
Sep 176.82
Aug 176.06
Aug 176.82
Aug 176.06
Aug 176.82
Free Cash Flow Yield
-25%-20%-15%-10%-5%0%med -1.68%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
TNR.V Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1.16%
Sep 26-1.19%
Sep 26-1.14%
Aug 26-1.07%
Aug 26-0.96%
Aug 26-0.96%
Aug 26-1.1%
Jul 26-1.12%
Jul 26-1.14%
Jul 26-1.29%
Jul 26-1.21%
Jul 26-1.16%
Jun 26-1.04%
Jun 26-1.04%
Jun 26-1%
Jun 26-1.21%
May 26-1.18%
May 26-1.04%
May 26-1.13%
May 26-1.18%
May 26-1.16%
Apr 26-1.04%
Apr 26-1.04%
Apr 26-1.11%
Apr 26-1.33%
Mar 26-0.57%
Mar 26-0.73%
Mar 26-0.75%
Mar 26-0.75%
Feb 26-0.78%
Feb 26-0.85%
Feb 26-0.78%
Feb 26-0.78%
Jan 26-0.75%
Jan 26-0.73%
Jan 26-0.73%
Jan 26-0.73%
Jan 26-0.8%
Dec 25-0.91%
Dec 25-0.97%
Dec 25-0.97%
Dec 25-1.03%
Nov 25-1.15%
Nov 25-1.19%
Nov 25-1.19%
Nov 25-1.72%
Oct 25-1.41%
Oct 25-1.35%
Oct 25-1.29%
Oct 25-1.24%
Oct 25-1.63%
Sep 25-2.97%
Sep 25-3.29%
Sep 25-3.29%
Sep 25-3.29%
Aug 25-3.29%
Aug 25-3.49%
Aug 25-3.49%
Aug 25-3.29%
Aug 25-3.29%
Jul 25-3.29%
Jul 25-3.29%
Jul 25-3.12%
Jul 25-3.29%
Jun 25-3.82%
Jun 25-4.02%
Jun 25-4.49%
Jun 25-4.02%
May 25-6.36%
May 25-6.36%
May 25-6.36%
May 25-5.87%
May 25-6.36%
Apr 25-6.94%
Apr 25-6.94%
Apr 25-6.36%
Apr 25-6.94%
Mar 25-15%
Mar 25-15%
Mar 25-16.36%
Mar 25-16.36%
Feb 25-13.85%
Feb 25-13.85%
Feb 25-16.36%
Feb 25-16.36%
Jan 25-18%
Jan 25-20%
Jan 25-18%
Jan 25-20%
Jan 25-20%
Dec 24-20.49%
Dec 24-18.44%
Dec 24-18.44%
Dec 24-18.44%
Nov 24-18.44%
Nov 24-18.44%
Nov 24-18.44%
Nov 24-18.44%
Nov 24-18.44%
Oct 24-16.77%
EV/EBITDA
0255075100med 1.38Oct 22Jan 23May 23Aug 23Dec 23Mar 24Jun 24
TNR.V EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 241.16
Jun 241.16
Jun 241.27
Jun 241.27
May 241.5
May 241.5
May 241.38
May 241.38
May 241.27
Apr 241.27
Apr 241.27
Apr 241.27
Apr 241.16
Mar 240.94
Mar 240.94
Mar 241.05
Mar 241.05
Mar 241.05
Feb 241.05
Feb 241.05
Feb 241.15
Feb 241.05
Jan 241.05
Jan 241.05
Jan 241.15
Jan 241.05
Dec 231.05
Dec 230.98
Dec 230.98
Dec 230.98
Dec 230.98
Nov 230.98
Nov 230.98
Nov 230.98
Nov 230.98
Oct 230.98
Oct 231.29
Oct 231.29
Oct 231.29
Sep 231.35
Sep 230.84
Sep 230.94
Sep 230.94
Sep 230.94
Aug 230.94
Aug 231.04
Aug 231.04
Aug 231.04
Jul 231.13
Jul 231.04
Jul 230.94
Jul 230.84
Jun 230.84
Jun 2320.87
Jun 2317.78
Jun 2318.81
Jun 2319.84
May 2318.81
May 2318.81
May 2318.81
May 2319.84
Apr 2321.9
Apr 2320.87
Apr 2319.84
Apr 2319.84
Mar 2320.87
Mar 2336.91
Mar 2336.91
Mar 2334.98
Mar 2334.98
Feb 2334.98
Feb 2333.05
Feb 2333.05
Feb 2334.98
Jan 2333.05
Jan 2331.12
Jan 2329.19
Jan 2329.19
Dec 2229.19
Dec 2274.53
Dec 2274.53
Dec 2279.56
Dec 2279.56
Nov 2274.53
Nov 2274.53
Nov 2269.51
Nov 2274.53
Oct 2274.53
Oct 2269.51
Oct 2269.51
Oct 2269.51
Sep 2269.51
Sep 2271.51
Sep 2276.77
Sep 2276.77
Sep 2271.51
Aug 2276.77
Aug 2276.77
Aug 2282.03
Aug 2282.03
Price to Book
050010001500med 65.33Apr 24Jul 24Nov 24Feb 25Nov 25Mar 26Jun 26
TNR.V Price to Book by quarter
PeriodPrice to Book
Jun 261325.47
Jun 261325.47
Jun 261377.45
Jun 261143.54
May 261169.53
May 261325.47
May 261221.51
May 261169.53
May 261195.52
Apr 261325.47
Apr 261325.47
Apr 261247.5
Apr 261039.58
Mar 26281.71
Mar 26219.11
Mar 26212.85
Mar 26212.85
Feb 26206.59
Feb 26187.81
Feb 26206.59
Feb 26206.59
Jan 26212.85
Jan 26219.11
Jan 26219.11
Jan 26219.11
Jan 26200.33
Dec 25105.35
Dec 2599.15
Dec 2599.15
Dec 2592.95
Nov 2583.66
Nov 2580.56
Nov 2580.56
Nov 2555.77
Oct 2568.16
Oct 2571.26
Oct 2574.36
Oct 2577.46
Oct 2558.87
Mar 2557.69
Mar 2557.69
Mar 2552.88
Mar 2552.88
Feb 2562.5
Feb 2562.5
Feb 2552.88
Feb 2552.88
Jan 2548.08
Jan 2543.27
Jan 2548.08
Jan 2543.27
Jan 2543.27
Dec 2490.73
Dec 24100.81
Dec 24100.81
Dec 24100.81
Nov 24100.81
Nov 24100.81
Nov 24100.81
Nov 24100.81
Nov 24100.81
Oct 24110.89
Oct 24110.89
Oct 24131.05
Oct 24120.97
Sep 2427.81
Sep 2427.81
Sep 2427.81
Sep 2427.81
Aug 2427.81
Aug 2427.81
Aug 2427.81
Aug 2427.81
Aug 2430.59
Jul 2430.59
Jul 2427.81
Jul 2430.59
Jul 2427.81
Jun 2416.98
Jun 2416.98
Jun 2418.53
Jun 2418.53
May 2421.61
May 2421.61
May 2420.07
May 2420.07
May 2418.53
Apr 2418.53
Apr 2418.53
Apr 2418.53
Apr 2416.98
Mar 248.76
Mar 248.76
Mar 249.64
Mar 249.64
Mar 249.64
Feb 249.64
Feb 249.64
Feb 2410.51
Feb 249.64
TNR Gold Corp.
TNR.V
Stockpicker

Video analysis: TNR.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TNR.V

TNR Gold wins ISS support in board battle

proactiveinvestors.com · 14 Sep 2026

TNR Gold wins ISS support in board battle

TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) has won the backing of proxy advisory firm Institutional Shareholder Services, which recommended shareholders...

ISS Rejects Eucalyptus' Demand for Full Board Change - Backs CEO Kirill Klip and Continuity at TNR Gold

feeds.newsfilecorp.com · 14 Sep 2026

ISS Rejects Eucalyptus' Demand for Full Board Change - Backs CEO Kirill Klip and Continuity at TNR Gold

Leading independent proxy advisor ISS states that "TNR outperformed its peer group over the three- and five-year periods ending on

TNR Gold royalty project Los Azules advances as McEwen Copper secures $240M term loan

proactiveinvestors.com · 10 Sep 2026

TNR Gold royalty project Los Azules advances as McEwen Copper secures $240M term loan

TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) said Thursday that McEwen Copper Inc. has closed a $240 million senior secured four-year term loan to advance...

Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Disclosure

gurufocus.com · 10 Sep 2026

Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Disclosure

Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Discl

Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Disclosure

prnewswire.com · 9 Sep 2026

Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Disclosure

All voting portals are now open - Eucalyptus Resources urges Shareholders to vote FOR the independent, highly qualified Eucalyptus Nominees on the GREEN proxy

TNR Gold Begins Exploration Program on Shotgun Gold Project in Alaska

feeds.newsfilecorp.com · 31 Aug 2026

TNR Gold Begins Exploration Program on Shotgun Gold Project in Alaska

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - TNR Gold Corp. (TSXV: TNR) ("TNR", "TNR Gold" or the "Company")

Dow rises as bond yields ease, Canada tariff pause lifts sentiment

proactiveinvestors.com · 19 Aug 2026

Dow rises as bond yields ease, Canada tariff pause lifts sentiment

11:20am: Treasury yields fall US Treasury yields fell sharply after the US government expanded long-dated bond buybacks, easing pressure on a market...

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

proactiveinvestors.com · 3 Aug 2026

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britain's biggest drugmaker is in talks to buy its US rival,...

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.